Pfizer is likely to seek authorization from the Food and Drug Administration for a coronavirus vaccine booster shot for people 18 and older as soon as this week, a government official with knowledge of the situation told ABC News.
The U.S. Centers for Disease Control and Prevention recommended the Pfizer booster shot for certain groups of patients six months after their second dose.
